More Resonance Health Ltd news
Resonance Health LtdASX: RHT

Results Recommending Use of FerriScan in Sickle Cell Disease

Nov 10, 2016 at 12:49 AM EST · Issued by Resonance Health Ltd

Filed with ASX · Nov 10, 2016 at 12:49 AM EST · 2 pages · English

On 6ix: 6ix.com/news/results-recommending-use-of-ferriscan-in-sickle-cell-disease

Resonance Health Ltd on 6ix

Story so far

  • New UK Standards recommend FerriScanMay 30, 2016

Earlier from Resonance Health

  • Resonance Health commences involvement in diabetes studyOct 13, 2016
  • Bone Marrow Iron - Regulatory SubmissionSep 23, 2016
  • Expansion of Involvement in Pharmaceutical Clinical TrialSep 7, 2016
  • HepaFat-Scan International Scientific JournalAug 10, 2016
  • Operational UpdateJun 14, 2016

Later from Resonance Health

  • Maylasian NAFLD - Diabetes StudyJan 12, 2017
  • Half year reportFeb 28, 2017
  • Cancer Survivor Campaign UpdateMar 23, 2017
  • Evidence Building for HepaFat-ScanApr 12, 2017
  • Quarterly ReportApr 28, 2017
All Resonance Health news releases↗

Follow Resonance Health into a list and get an email when it puts out news.

Follow Resonance Health
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer